AAOS establishes Orthobiologics Registry to advance evidence-based orthobiologics research

AAOS announced the development of the AAOS Orthobiologics Registry (OBR), a disease- and condition-focused registry designed to measure the long-term safety, efficacy, and real-world outcomes of orthobiologic therapies for patients diagnosed with knee osteoarthritis.

Jason Dragoo, MD, highlights AAOS’ current and future biologics initiatives designed to support orthopaedic care

Robert M. Orfaly, MD, MBA, FAAOS

AAOS Now Editor-in-Chief Robert M. Orfaly, MD, MBA, FAAOS, sat down with Jason Dragoo, MD, FAAOS, chair of the AAOS Devices, Biologics, and Technology (DBT) Committee, to discuss what is new in orthobiologics.